位置:成果数据库 > 期刊 > 期刊详情页
非选择性内皮素受体拮抗剂CPU0213改善感染性休克小鼠/大鼠的血管活性
  • ISSN号:1003-3734
  • 期刊名称:《中国新药杂志》
  • 时间:0
  • 分类:R965.1[医药卫生—药理学;医药卫生—药学] R631.4[医药卫生—临床医学;医药卫生—外科学]
  • 作者机构:[1]中国药科大学药理学研究室,南京210009, [2]东南大学药物化学系,南京210009
  • 相关基金:国家自然科学基金重点项目(30230170)
中文摘要:

目的:通过非选择性内皮素受体拮抗剂CPU20213对结扎小鼠和大鼠盲肠并穿孔致感染性休克血管活性的改善,探讨其通过干预内皮素-活性氧(ET-ROS)轴心治疗感染性休克可能的作用机制.方法:结扎小鼠盲肠并穿孔,8 h后按30 mg·kg-1皮下注射(sc)CPU0213,bid×3 d.观察术后该时间段的存活率,计算腹腔渗出液重量,生命器官脏器系数,心肌、肾匀浆和血清丙二醛(MDA),谷胱甘肽过氧化物酶(GSH-PX)含量及胸主动脉血管活性;同样方法结扎大鼠盲肠,检测血浆ET-1浓度和肠系膜血管ETA和ETB受体mRNA表达.结果:模型组小鼠存活率明显降低,生命器官脏器系数明显增加,腹腔渗出液显著增多,GSH-PX活性下降,MDA含量增加,血管收缩和舒张功能及NO生物利用度明显降低;大鼠血浆ET-1浓度显著升高,肠系膜血管ETA和ETB受体mRNA表达上调;CPU20213治疗后,均有不同程度改善.结论:CPU0213通过阻断ET-ROS轴心,改善血管活性,减少腹腔渗出液,提高存活率.

英文摘要:

Objective:To assess the amelioration of a non-selective endothelin (ETA/ETB ) receptor antagonist CPU0213 on vascular activity of septic shock mice/rats induced by cecal ligation and puncture (CLP) , and explore its possible mechanism. Methods:In 8 hours after the CLP, mice were subcutaneously administered with CPU0213 (30 rag·kg^-1) twice daily for 3 days. The survival rate, peritoneal exudates, indexes of important organs in the 3-day course post the CLP were monitored; MDA and GSH-PX levels in serum, heart and kidney were detected, and the activity of aorta peetoralis were measured. Rats that underwent the same CLP procedure were studied in the plasma endothelin-1 levels and mRNA expression of ETA, ETs receptors of mesenteric blood vessel. Results:The survival rate and vascular activity ( vascular tension, relaxation and NO bioavailability) of thoracic aorta were significantly decreased, the weight indexes of vital organs and the weight of peritoneal exudates were remarkably increased, and also the abnormal levels of MDA and GSH-PX appeared in mice of model group. The ET-1 levels and mRNA expression of ETA, ETB receptors of mesenterie blood vessel were markedly increased in rats of model group. All of those were reversed significantly after treatment with CPU0213. Conclusion: CPU0213 lessehed the impaired vascular activity, abdominal effusion, and in- creased survival rate by intervening ET-l-reactive oxygen species pathway.

同期刊论文项目
同项目期刊论文
期刊信息
  • 《中国新药杂志》
  • 中国科技核心期刊
  • 主管单位:国家药品监督管理局
  • 主办单位:中国医药科技出版社 中国医药(集团)公司 中国药学会
  • 主编:桑国卫
  • 地址:北京海淀区中关村东路123号B座1605室
  • 邮编:100086
  • 邮箱:
  • 电话:010-82282300
  • 国际标准刊号:ISSN:1003-3734
  • 国内统一刊号:ISSN:11-2850/R
  • 邮发代号:82-488
  • 获奖情况:
  • 全国中文核心期刊,中国期刊方阵“双效”期刊,中国科技核心期刊
  • 国内外数据库收录:
  • 美国国际药学文摘,美国化学文摘(网络版),荷兰文摘与引文数据库,荷兰医学文摘,日本日本科学技术振兴机构数据库,中国中国科技核心期刊,中国北大核心期刊(2004版),中国北大核心期刊(2008版),中国北大核心期刊(2011版),中国北大核心期刊(2014版),中国北大核心期刊(2000版)
  • 被引量:42503